I Epidemiology of gallstone disease today.- 1 Why talk about epidemiology of gallstone disease?.- 2 Findings on gallstone disease in the ISTAT investigation.- 3 The GREPCO research programmes: aims and prevalence data.- 4 Epidemiology of cholelithiasis in the Pima Indians.- 5 Epidemiology of gallstone disease: the ‘Sirmione Study’.- 6 Epidemiology of gallstone disease in Chile.- 7 Cholecystolithiasis in a Danish community; design of a cross-sectional and longitudinal study.- II Metabolic aspects of gallstone disease and lessons from epidemiology.- 8 Physicochemical aspects of cholesterol gallstone formation.- 9 Metabolic factors in pathogenesis of cholesterol gallstones: implications for gallstone prevention.- 10 Classification and pathogenesis of pigment gallstones.- 11 Epidemiological and biochemical aspects of an important sequel to cholelithiasis: gallbladder cancer.- 12 Relationships between serum lipids and cholelithiasis: observations in the GREPCO study.- 13 Diabetes mellitus, obesity and cholelithiasis.- 14 High-density lipoprotein-cholesterol and the risk of gallbladder disease.- 15 Intestinal metabolism of bile acids and cholelithiasis.- 3 Data from epidemiology and from trials: lessons for clinical practice.- 16 Gallbladder ultrasonography as a diagnostic tool in epidemiological screenings.- 17 Epidemiology and medical treatment of cholesterol gallstones: recurrence, post-dissolution management and the future.- 18 The role of diet in the aetiology of cholelithiasis.- 19 Pathogenic and clinical relationships between endemic salmonellosis and gallstone disease.- 20 Clinical symptoms and gallstone disease: lessons from a population study.- 21 Problems in determining the prognosis of asymptomatic gallstones.- 22 Cholecystectomy and large bowel cancer.- 23Dietary habits and cholelithiasis.- 4 Prevention of gallstone disease: present status.- 24 Factors associated with gallstone disease: Observations in the GREPCO study.- 2 5 Prevention of coronary heart disease and risk of cholelithiasis.- 26 Long-term natural history of silent gallstones: implications for secondary prevention.- 27 Factors associated with gallstone disease: observations in the ‘Sirmione Study’.- 28 Prevention of cholelithiasis: intervention on risk factors.- APPENDIX Logistic regression analysis in epidemiological research.
